ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
ANI Pharmaceuticals announced that CEO Nikhil Lalwani will present at the 2024 Jefferies Global Healthcare Conference in New York City. The presentation is scheduled for June 5, 2024, at 4:30 PM ET. Interested parties can attend the webcast through a provided link or schedule 1-on-1 meetings by contacting their Jefferies representative.
- CEO Nikhil Lalwani's participation at a prestigious event like the Jefferies Global Healthcare Conference could enhance ANI Pharmaceuticals' visibility and investor confidence.
- The presentation offers an opportunity to highlight recent achievements and future plans, potentially attracting new investors.
- The press release lacks detailed information on financial performance or new product developments, which could lead to investor uncertainty.
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows:
Date: | June 5, 2024 |
Time: | 4:30 ET |
Webcast: | Click Here |
To schedule a 1x1 meeting with the Company, please contact your Jefferies representative.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset Purified Cortrophin® Gel, strengthening its Generics business with enhanced research and development capabilities, delivering innovation in Established Brands, and leveraging its U.S. based manufacturing footprint. For more information, please visit our website www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
![](https://ml.globenewswire.com/media/Mzg0YzBiMzYtYjIxNy00ODQzLTlkN2QtZTg3ZjQyZWEwNjAyLTEwMzA4MzM=/tiny/ANI-Pharmaceuticals-Inc-.png)
FAQ
When will ANI Pharmaceuticals present at the 2024 Jefferies Global Healthcare Conference?
Who will represent ANI Pharmaceuticals at the 2024 Jefferies Global Healthcare Conference?
Where will the 2024 Jefferies Global Healthcare Conference take place?